Jeff Lagasse
The five new ventilator contracts are expected to ramp up production, while immunotherapy development could help in coronavirus treatment.
Having rolling budget forecasting, following coding guidelines and anticipating patient behavior changes will help with the coronavirus aftermath.
The guidance is meant to remove financial barriers for receiving coronavirus tests and health services, and to encourage antibody testing.
The funding is unlikely to fully compensate providers for the revenue hit caused by cancelled elective surgeries and by labor and PPE costs.
Actions included reducing operating room volume by 80% to ensure adequate capacity to care for an anticipated influx of coronavirus patients.
After so many hours wearing this form of personal protective equipment, skin can tear, increasing the likelihood of infection.
The guidance is meant to empower local hospitals and healthcare systems to rapidly expand their capacity to treat coronavirus patients.
While new technologies are being deployed, health systems can use existing resources to help combat the coronavirus's spread.
The data was gathered before COVID-19 began its spread across the globe, meaning the outlook for rural hospitals may yet worsen.
If the current pandemic continues much longer, acquiring needed ventilator medications will present long-term challenges for patient care.